Is MED or MKC more undervalued in 2026?

CirclFi compares MEDIFAST INC (MED) and McCormick & Company, Incorporat (MKC) using 13 institutional-grade valuation models. MED has a Quality of Company score of 7.0/10 while MKC scores 8.1/10.

Which is a better buy — MED or MKC?

Compare intrinsic values from 13 independent models against current market prices. CirclFi also calculates Value Trap scores. This is not financial advice — conduct your own analysis.

How do MED and MKC valuations compare?

MED at $12.53 and MKC at $47.37 are compared across Bayesian DCF, EPV, EROIC Spread, First Chicago, Markov DDM, and 8 additional models.

MED vs MKC Valuation Comparison 2026 — Intrinsic Value Analysis

MED

Miscellaneous Food Preparations & Kindred Products

MEDIFAST INC

Quality

7.0

out of 10

Value Trap

SAFE

Price

$12.53

Last close

Models

12/13

Active

MKC

Miscellaneous Food Preparations & Kindred Products

McCormick & Company, Incorporat

Quality

8.1

out of 10

Value Trap

—

Price

$47.37

Last close

Models

12/13

Active

Model-by-Model Comparison

Model	Type	MED Fair Value	MED Upside	MKC Fair Value	MKC Upside
Bayesian DCF	Intrinsic	$62.34	+397.5%	$23.39	-50.6%
Earnings Power Value	Intrinsic	$5.12	-59.1%	$9.87	-79.2%
EROIC Spread	Intrinsic	$•••.••	••.•%	$•••.••	••.•%
First Chicago	Scenario	$•••.••	••.•%	$•••.••	••.•%
Markov DDM	Intrinsic	$•••.••	••.•%	$•••.••	••.•%
ML-RIV	Intrinsic	$•••.••	••.•%	$•••.••	••.•%
Dynamic NAV	Asset-Based	$•••.••	••.•%	$•••.••	••.•%
PWERM	Option-Based	$•••.••	••.•%	$•••.••	••.•%
Regime Cross-Sectional	Relative	$•••.••	••.•%	$•••.••	••.•%
Sentiment SOTP	Hybrid	$•••.••	••.•%	$•••.••	••.•%
CUCE Ensemble	Ensemble	$•••.••	••.•%	$•••.••	••.•%
FTNN Topology	Relative	$•••.••	••.•%	$•••.••	••.•%
RCMH-DCF	Intrinsic	$•••.••	••.•%	$•••.••	••.•%

🔒

Unlock Full 13-Model Comparison

Access all valuation models for MED vs MKC — including EROIC Spread, First Chicago, Markov DDM, PWERM, and 7 more.

Access Full Analysis — From $27/mo →

MED vs MKC — Which Stock Is More Undervalued?

MKC scores higher with a 8.1/10 quality rating vs MED's 7.0/10. Both stocks are analyzed daily using SEC EDGAR filings across 13 independent models.

Comparing MEDIFAST INC (MED) and McCormick & Company, Incorporat (MKC) across 13 institutional-grade valuation models reveals how each company's intrinsic value stacks up against its market price. CirclFi's engine processes SEC EDGAR 10-K and 10-Q filings, FRED macroeconomic data, and GDELT news sentiment to generate independent fair value estimates daily.

MED currently trades at $12.53 with a QOC of 7.0/10, while MKC trades at $47.37 with a QOC of 8.1/10.

Both companies are analyzed with models spanning intrinsic (Bayesian DCF, EPV), scenario-based (First Chicago), regime-switching (Markov DDM, RCMH-DCF), machine learning (ML-RIV, FTNN Topology), and ensemble methods (CUCE).